NYSE:LH - Laboratory Co. of America Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $276.08
Forecasted Upside: 6.56 %
Number of Analysts: 11
Breakdown:
0 Sell Ratings
0 Hold Ratings
11 Buy Ratings
0 Strong Buy Ratings

^$259.09 As of 06/16/2021 01:00 AM ET

▼ -1.34 (-0.51%)

1 month | 3 months | 12 months

Get New Laboratory Co. of America Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for LH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LH

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$276.08

▲ +6.56% Upside Potential

This price target is based on 11 analysts offering 12 month price targets for Laboratory Co. of America in the last 3 months. The average price target is $276.08, with a high forecast of $320.00 and a low forecast of $217.00. The average price target represents a 6.56% upside from the last price of $259.09.

Buy

The current consensus among 11 investment analysts is to buy stock in Laboratory Co. of America. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
9 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

12/24/2019

0 strong buy ratings
10 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

3/23/2020

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

6/21/2020

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

9/19/2020

0 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

12/18/2020

0 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

3/18/2021

0 strong buy ratings
13 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

5/17/2021

0 strong buy ratings
11 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

6/16/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
5/20/2021	Argus	Boost Price Target	Average ➝ Buy	$270.00 ➝ $295.00	Medium	i
5/12/2021	Mizuho	Boost Price Target	Buy	$267.00 ➝ $310.00	Low	i
5/3/2021	Truist	Boost Price Target		$300.00 ➝ $320.00	Low	i
5/3/2021	Citigroup	Boost Price Target		$278.00 ➝ $312.00	Low	i
5/3/2021	Jefferies Financial Group	Boost Price Target	Buy	$300.00 ➝ $310.00	Low	i
4/14/2021	Truist	Boost Price Target		$280.00 ➝ $300.00	High	i
4/14/2021	Truist Securities	Boost Price Target	Above Average ➝ Buy	$280.00 ➝ $300.00	Medium	i
4/1/2021	Jefferies Financial Group	Reiterated Rating	Buy		High	i
2/12/2021	Citigroup	Boost Price Target	Buy	$257.00 ➝ $278.00	Low	i
2/12/2021	JPMorgan Chase & Co.	Boost Price Target	Overweight	$261.00 ➝ $279.00	Low	i
2/12/2021	Mizuho	Boost Price Target	Buy	$242.00 ➝ $267.00	Low	i
1/29/2021	Citigroup	Boost Price Target	Buy	$249.00 ➝ $257.00	Low	i
1/14/2021	Mizuho	Boost Price Target	Buy	$234.00 ➝ $242.00	Low	i
1/11/2021	Argus	Upgrade	Hold ➝ Buy	$245.00	Medium	i
1/8/2021	Wolfe Research	Downgrade	Outperform ➝ Peer Perform		High	i Rating by Steve Baxter at Wolfe Research
10/28/2020	Wells Fargo & Company	Boost Price Target	Overweight	$225.00 ➝ $260.00	Low	i
10/28/2020	Mizuho	Boost Price Target	Buy	$215.00 ➝ $234.00	Low	i
10/27/2020	William Blair	Reiterated Rating	Outperform		Low	i Rating by M. Larew at William Blair
10/14/2020	Jefferies Financial Group	Boost Price Target	Buy	$183.00 ➝ $230.00	Low	i
7/31/2020	Mizuho	Boost Price Target	Buy	$186.00 ➝ $215.00	Low	i
7/29/2020	Bank of America	Boost Price Target	Buy	$220.00 ➝ $240.00	Medium	i Rating by Derik De Bruin at Bank of America Co.
7/29/2020	SunTrust Banks	Boost Price Target	Positive ➝ Buy	$220.00 ➝ $240.00	Medium	i
7/29/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$210.00 ➝ $230.00	Medium	i Rating by Pito Chickering at Deutsche Bank Aktiengesellschaft
7/29/2020	Citigroup	Boost Price Target	Buy	$214.00 ➝ $249.00	Medium	i
7/14/2020	Bank of America	Upgrade	Neutral ➝ Buy	$194.00 ➝ $220.00	High	i
7/13/2020	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$202.00 ➝ $217.00	High	i Rating by Steve Baxter at Wolfe Research
6/10/2020	Wells Fargo & Company	Reiterated Rating	Buy		Medium	i
6/8/2020	Robert W. Baird	Boost Price Target	Outperform	$199.00 ➝ $219.00	Medium	i
6/4/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$118.00 ➝ $223.00	Medium	i
6/2/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$210.00	Medium	i
5/21/2020	SunTrust Banks	Boost Price Target	Buy	$200.00 ➝ $220.00	Medium	i
5/20/2020	Morgan Stanley	Boost Price Target	Overweight	$241.00 ➝ $244.00	Low	i
5/15/2020	Mizuho	Upgrade	Neutral ➝ Buy	$158.00 ➝ $186.00	Low	i
5/5/2020	UBS Group	Boost Price Target	Buy	$209.00 ➝ $218.00	Low	i
4/30/2020	JPMorgan Chase & Co.	Boost Price Target		$149.00 ➝ $188.00	Medium	i
4/30/2020	Morgan Stanley	Boost Price Target	Overweight	$172.00 ➝ $241.00	Medium	i
4/30/2020	Bank of America	Boost Price Target	Neutral	$147.00 ➝ $190.00	Medium	i
4/29/2020	KeyCorp	Downgrade	Overweight ➝ Sector Weight		Medium	i
4/27/2020	Wolfe Research	Upgrade	Underperform ➝ Market Perform	$188.00	Medium	i
4/27/2020	Citigroup	Upgrade	Neutral ➝ Buy	$204.00 ➝ $214.00	High	i
4/23/2020	Barclays	Boost Price Target	Overweight	$188.00 ➝ $195.00	Medium	i
4/16/2020	Mizuho	Lower Price Target	Neutral	$163.00 ➝ $158.00	Medium	i
4/13/2020	SunTrust Banks	Lower Price Target	Buy	$225.00 ➝ $200.00	Medium	i
4/8/2020	Morgan Stanley	Lower Price Target	Overweight	$211.00 ➝ $172.00	High	i
4/2/2020	JPMorgan Chase & Co.	Lower Price Target	Overweight	$182.00 ➝ $149.00	Medium	i
3/30/2020	Wells Fargo & Company	Lower Price Target	Overweight	$215.00 ➝ $170.00	Medium	i
3/30/2020	KeyCorp	Lower Price Target	Overweight	$212.00 ➝ $170.00	High	i
3/26/2020	Barclays	Lower Price Target	Overweight	$212.00 ➝ $188.00	Low	i
3/24/2020	JPMorgan Chase & Co.	Lower Price Target	Overweight	$204.00 ➝ $182.00	High	i
2/25/2020	Mizuho	Boost Price Target	Neutral	$174.00 ➝ $190.00	High	i
2/18/2020	Morgan Stanley	Boost Price Target	Overweight	$199.00 ➝ $211.00	Medium	i Rating by Ricky Goldwasser at Morgan Stanley
2/14/2020	Evercore ISI	Initiated Coverage	Buy	$215.00	Medium	i Rating by Michael Newshel at Evercore ISI
2/14/2020	Citigroup	Boost Price Target	Neutral	$179.00 ➝ $204.00	Low	i
2/13/2020	Piper Sandler	Boost Price Target		$177.00 ➝ $219.00	Low	i
1/7/2020	Wells Fargo & Company	Initiated Coverage	Overweight	$210.00	High	i
1/3/2020	Bank of America	Downgrade	Neutral ➝ Underperform		Low	i
10/24/2019	Canaccord Genuity	Reiterated Rating	Hold	$170.00	Low	i
10/21/2019	UBS Group	Lower Price Target	Buy	$204.00 ➝ $200.00	Low	i
8/23/2019	Morgan Stanley	Boost Price Target	Overweight	$190.00 ➝ $201.00	Medium	i Rating by Ricky Goldwasser at Morgan Stanley
8/8/2019	KeyCorp	Boost Price Target	Overweight	$172.00 ➝ $192.00	Medium	i
7/26/2019	Morgan Stanley	Boost Price Target	Overweight	$175.00 ➝ $190.00	High	i Rating by Ricky Goldwasser at Morgan Stanley
7/16/2019	Bank of America	Upgrade	Underperform ➝ Neutral	$174.60	Low	i
7/15/2019	Barclays	Set Price Target	Buy	$200.00	Low	i Rating by Jack Meehan at Barclays PLC
6/20/2019	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy	$180.00 ➝ $220.00	High	i
5/20/2019	Mizuho	Boost Price Target	Neutral	$150.00 ➝ $174.00	Low	i
5/2/2019	Canaccord Genuity	Boost Price Target	Hold ➝ Hold	$155.00 ➝ $165.00	Low	i
5/1/2019	Citigroup	Boost Price Target	Neutral ➝ Neutral	$157.00 ➝ $176.00	Low	i
5/1/2019	UBS Group	Boost Price Target	Buy ➝ Buy	$178.00 ➝ $195.00	Low	i Rating by Kevin Caliendo at UBS Group AG
4/2/2019	Wolfe Research	Initiated Coverage	Underperform		Low	i
4/2/2019	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$154.00 ➝ $190.00	Medium	i
3/18/2019	Barclays	Boost Price Target	Overweight ➝ Overweight	$165.00 ➝ $173.00	Low	i
2/27/2019	Credit Suisse Group	Boost Price Target	Outperform ➝ Outperform	$160.00 ➝ $164.00	Low	i
2/22/2019	Morgan Stanley	Set Price Target	Buy	$175.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
2/8/2019	UBS Group	Set Price Target	Buy	$178.00	Low	i Rating by Kevin Caliendo at UBS Group AG
1/17/2019	UBS Group	Initiated Coverage	Buy ➝ Buy	$169.00	High	i
1/3/2019	Bank of America	Downgrade	Neutral ➝ Underperform		Medium	i
12/20/2018	Morgan Stanley	Set Price Target	Buy	$177.00	Medium	i Rating by Ricky Goldwasser at Morgan Stanley
12/9/2018	The Goldman Sachs Group	Lower Price Target		$190.00 ➝ $180.00	Low	i Rating by Patrick B Donnelly at The Goldman Sachs Group, Inc.
12/9/2018	Morgan Stanley	Lower Price Target		$202.00 ➝ $180.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
12/6/2018	KeyCorp	Lower Price Target	Overweight ➝ Overweight	$210.00 ➝ $165.00	Low	i
12/3/2018	SunTrust Banks	Lower Price Target	Buy	$175.00	Low	i
12/3/2018	Barclays	Lower Price Target	Overweight ➝ Overweight	$205.00 ➝ $165.00	Medium	i
12/3/2018	Citigroup	Lower Price Target	Neutral ➝ Neutral	$171.00 ➝ $160.00	Medium	i
12/3/2018	William Blair	Reiterated Rating	Buy		Medium	i Rating by Matt Larew at William Blair
12/3/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$202.00 ➝ $180.00	Medium	i Rating by Ricky Goldwasser at Morgan Stanley
12/3/2018	Bank of America	Downgrade	Buy ➝ Neutral		Medium	i
12/3/2018	Craig Hallum	Downgrade	Buy ➝ Hold		Medium	i
12/2/2018	Canaccord Genuity	Reiterated Rating	Hold ➝ Hold	$162.00 ➝ $155.00	Medium	i
12/2/2018	The Goldman Sachs Group	Lower Price Target		$190.00	Medium	i
11/30/2018	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy	$190.00 ➝ $180.00	High	i
10/30/2018	Argus	Downgrade	Buy ➝ Hold		Low	i
10/25/2018	Robert W. Baird	Lower Price Target	Outperform	$205.00 ➝ $190.00	Low	i Rating by Eric Coldwell at Robert W. Baird
10/25/2018	Citigroup	Lower Price Target	Neutral	$184.00 ➝ $171.00	Low	i
10/25/2018	Mizuho	Set Price Target	Hold	$169.00	Low	i Rating by Ann Hynes at Mizuho
10/25/2018	Canaccord Genuity	Downgrade	Buy ➝ Hold	$190.00 ➝ $162.00	Low	i
10/24/2018	William Blair	Reiterated Rating	Outperform		Medium	i Rating by M. Larew at William Blair
10/19/2018	Bank of America	Initiated Coverage	Buy ➝ Buy		Low	i
10/3/2018	Craig Hallum	Lower Price Target	Buy	$201.00 ➝ $193.00	Low	i
9/19/2018	Mizuho	Reiterated Rating	Neutral		Low	i Rating by A. Hynes at Mizuho
9/10/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Buy	$192.00 ➝ $202.00	Low	i
9/4/2018	Credit Suisse Group	Lower Price Target	Outperform ➝ Outperform	$197.00 ➝ $195.00	Medium	i
8/22/2018	Argus	Reiterated Rating	Buy		Low	i
8/20/2018	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold ➝ Hold	$195.00 ➝ $190.00	Medium	i Rating by Dan Leonard at Deutsche Bank Aktiengesellschaft
7/26/2018	Mizuho	Reiterated Rating	Hold	$189.00	Low	i Rating by Ann Hynes at Mizuho
7/26/2018	Jefferies Financial Group	Reiterated Rating	Hold ➝ Neutral	$180.00	Low	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
7/24/2018	Canaccord Genuity	Reiterated Rating	Buy	$200.00	High	i
7/20/2018	SunTrust Banks	Reiterated Rating	Buy	$220.00	Low	i
6/27/2018	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$172.00	Medium	i
6/7/2018	KeyCorp	Upgrade	Sector Weight ➝ Overweight	$210.00	Low	i
5/25/2018	Barclays	Boost Price Target	Equal Weight ➝ Overweight	$210.00 ➝ $220.00	High	i
5/25/2018	Mizuho	Reiterated Rating	Hold		High	i Rating by Ann Hynes at Mizuho
5/1/2018	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$183.00 ➝ $203.00	Low	i Rating by Eric Coldwell at Robert W. Baird
3/23/2018	Argus	Initiated Coverage	Buy	$202.00	High	i
3/8/2018	Credit Suisse Group	Reiterated Rating	Outperform ➝ Outperform	$192.00 ➝ $195.00	Low	i
3/6/2018	Jefferies Financial Group	Reiterated Rating	Hold	$176.00	Medium	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
3/1/2018	Credit Suisse Group	Reiterated Rating	Outperform ➝ Outperform	$190.00 ➝ $192.00	Medium	i
2/28/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$182.00 ➝ $192.00	Medium	i
2/28/2018	Canaccord Genuity	Boost Price Target	Buy ➝ Buy	$190.00 ➝ $195.00	Medium	i
2/26/2018	Barclays	Boost Price Target	Overweight ➝ Overweight	$195.00 ➝ $210.00	Medium	i
2/9/2018	Citigroup	Boost Price Target	Neutral ➝ Neutral	$161.00 ➝ $184.00	Medium	i
2/8/2018	Robert W. Baird	Set Price Target	Neutral ➝ Hold	$150.00 ➝ $183.00	High	i Rating by Whit Mayo at Robert W. Baird
2/7/2018	Craig Hallum	Reiterated Rating	Buy	$180.00 ➝ $204.00	Low	i
1/29/2018	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Buy	$128.00 ➝ $205.00	Low	i
1/24/2018	Mizuho	Set Price Target	Hold	$178.00	Low	i Rating by Ann Hynes at Mizuho
1/4/2018	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$176.00	High	i
12/13/2017	Barclays	Reiterated Rating	Buy	$195.00	Low	i
12/1/2017	Mizuho	Set Price Target	Neutral ➝ Neutral	$160.00 ➝ $165.00	Medium	i Rating by Ann Hynes at Mizuho
11/24/2017	Jefferies Financial Group	Set Price Target	Hold	$167.00	Low	i
10/27/2017	Robert W. Baird	Reiterated Rating	Hold	$150.00	N/A	i
10/26/2017	Barclays	Boost Price Target	Overweight	$183.00 ➝ $190.00	N/A	i
10/26/2017	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$170.00 ➝ $172.00	N/A	i
10/26/2017	Craig Hallum	Reiterated Rating	Buy	$175.00 ➝ $180.00	N/A	i
10/20/2017	Jefferies Financial Group	Reiterated Rating	Hold	$170.00	N/A	i
10/17/2017	Robert W. Baird	Reiterated Rating	Hold	$166.00	N/A	i
10/12/2017	SunTrust Banks	Reiterated Rating	Buy	$190.00	N/A	i
10/12/2017	Wells Fargo & Company	Initiated Coverage	Market Perform ➝ Outperform	$175.00	N/A	i
9/26/2017	KeyCorp	Reiterated Rating	Hold		Low	i
9/17/2017	Robert W. Baird	Reiterated Rating	Neutral ➝ Hold		Low	i
9/13/2017	Jefferies Financial Group	Reiterated Rating	Hold	$157.00 ➝ $170.00	Medium	i
9/11/2017	Canaccord Genuity	Reiterated Rating	Buy	$175.00 ➝ $180.00	Medium	i
8/10/2017	Morgan Stanley	Boost Price Target	Overweight	$154.00 ➝ $166.00	Low	i
7/27/2017	Barclays	Boost Price Target	Overweight	$182.00 ➝ $183.00	Low	i Rating by Jack Meehan at Barclays PLC
7/27/2017	Craig Hallum	Reiterated Rating	Buy	$157.00 ➝ $179.00	Medium	i
7/17/2017	Barclays	Reiterated Rating	Overweight	$175.00 ➝ $182.00	Low	i Rating by Jack Meehan at Barclays PLC
7/13/2017	Credit Suisse Group	Downgrade	Hold	$146.00	Low	i
5/28/2017	Credit Suisse Group	Reiterated Rating	Buy	$146.00	Medium	i
4/28/2017	Jefferies Financial Group	Lower Price Target	Hold	$159.00 ➝ $157.00	Low	i
3/7/2017	Barclays	Boost Price Target	Overweight ➝ Overweight	$165.00 ➝ $175.00	N/A	i Rating by Jack Meehan at Barclays PLC
2/18/2017	Barclays	Set Price Target	Buy	$165.00	N/A	i Rating by Jack Meehan at Barclays PLC
2/17/2017	Jefferies Financial Group	Reiterated Rating	Hold	$159.00	N/A	i
2/17/2017	Canaccord Genuity	Boost Price Target	Buy	$140.00 ➝ $150.00	N/A	i Rating by Mark Massaro at Canaccord Genuity
2/17/2017	Mizuho	Boost Price Target	Neutral	$135.00 ➝ $139.00	N/A	i
2/6/2017	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$138.00	N/A	i
1/23/2017	Canaccord Genuity	Set Price Target	Buy	$140.00	N/A	i Rating by Mark Massaro at Canaccord Genuity
1/18/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$170.00	N/A	i
1/17/2017	Canaccord Genuity	Set Price Target	Buy	$140.00	N/A	i Rating by Mark Massaro at Canaccord Genuity
10/30/2016	Canaccord Genuity	Set Price Target	Buy	$140.00	N/A	i Rating by Mark Massaro at Canaccord Genuity
10/25/2016	Gabelli	Initiated Coverage	Buy	$180.00	N/A	i Rating by S. Wojda at Gabelli
9/15/2016	Mizuho	Boost Price Target	Neutral	$132.00 ➝ $145.00	N/A	i
9/14/2016	Canaccord Genuity	Set Price Target	Buy	$155.00	N/A	i Rating by mark massaro at Canaccord Genuity
9/9/2016	Citigroup	Initiated Coverage	Neutral	$156.00	N/A	i
8/29/2016	Barclays	Set Price Target	Buy	$155.00	N/A	i
8/16/2016	KeyCorp	Boost Price Target	Overweight	$143.00 ➝ $150.00	N/A	i Rating by Donald Hooker at KeyCorp
7/28/2016	SunTrust Banks	Reiterated Rating	Buy		N/A	i Rating by David S Macdonald at SunTrust Banks, Inc.
7/28/2016	Canaccord Genuity	Set Price Target	Buy	$155.00	N/A	i Rating by Mark Massaro at Canaccord Genuity
7/28/2016	UBS Group	Boost Price Target	Neutral	$125.00 ➝ $137.50	N/A	i
7/27/2016	Evercore ISI	Boost Price Target	Buy	$147.00 ➝ $155.00	N/A	i

(Data available from 6/16/2016 forward)

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. In addition, it provides online and mobile applications to enable patients to check test results; patient self-service apps; and online applications for managed care organizations. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Today's Range

Now: $259.09

$258.00

$260.81

50 Day Range

MA: $266.26

$252.02

$278.14

52 Week Range

Now: $259.09

$155.65

$280.69

Volume

551,628 shs

Average Volume

705,304 shs

Market Capitalization

$25.31 billion

P/E Ratio

9.63

Dividend Yield

N/A

Beta

1.04

Frequently Asked Questions

What sell-side analysts currently cover shares of Laboratory Co. of America?

The following sell-side analysts have issued stock ratings on Laboratory Co. of America in the last year: Argus, Bank of America Co., Citigroup Inc., Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, SunTrust Banks, Inc., TheStreet, Truist, Truist Securities, Wells Fargo & Company, William Blair, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for LH.

What is the current price target for Laboratory Co. of America?

12 Wall Street analysts have set twelve-month price targets for Laboratory Co. of America in the last year. Their average twelve-month price target is $276.08, suggesting a possible upside of 6.2%. Truist has the highest price target set, predicting LH will reach $320.00 in the next twelve months. Wolfe Research has the lowest price target set, forecasting a price of $217.00 for Laboratory Co. of America in the next year.
View the latest price targets for LH.

What is the current consensus analyst rating for Laboratory Co. of America?

Laboratory Co. of America currently has 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe LH will outperform the market and that investors should add to their positions of Laboratory Co. of America.
View the latest ratings for LH.

What other companies compete with Laboratory Co. of America?

Other companies that are similar to Laboratory Co. of America include Quest Diagnostics, DaVita, Amedisys, Chemed, LHC Group, R1 RCM, AMN Healthcare Services, MEDNAX, CorVel, Tivity Health and Cross Country Healthcare.

How do I contact Laboratory Co. of America's investor relations team?

Laboratory Co. of America's physical mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company's listed phone number is 336-229-1127 and its investor relations email address is [email protected] The official website for Laboratory Co. of America is www.labcorp.com.